[1] |
PURCAREA A, SOVAILA S. Sepsis, a 2020 review for the internistJ[J]. Rom J Intern Med, 2020, 58(3):129-137.
|
[2] |
SINGER M, DEUTSCHMAN C S, SEYMOUR C W, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)[J]. JAMA, 2016, 315(8):801-810.
doi: 10.1001/jama.2016.0287
pmid: 26903338
|
[3] |
KORHONEN E A, LAMPINEN A, GIRI H, et al. Tie1 controls angiopoietin function in vascular remodeling and inflammation[J]. J Clin Invest, 2016, 126(9):3495-3510.
doi: 10.1172/JCI84923
pmid: 27548530
|
[4] |
TEICHERT M, MILDE L, HOLM A, et al. Pericyte-expressed Tie2 controls angiogenesis and vessel maturation[J]. Nat Commun, 2017, 8:16106.
doi: 10.1038/ncomms16106
pmid: 28719590
|
[5] |
BRAUN L J, ZINNHARDT M, VOCKEL M, et al. VE-PTP inhibition stabilizes endothelial junctions by activa-ting FGD5[J]. EMBO Rep, 2019, 20(7):e47046.
|
[6] |
LEE S J, LEE C K, KANG S, et al. Angiopoietin-2 exa-cerbates cardiac hypoxia and inflammation after myocardial infarction[J]. J Clin Invest, 2018, 128(11):5018-5033.
|
[7] |
SALIMI U, MENDEN H L, MABRY S M, et al. Angiopoie-tin-1 protects against endotoxin-induced neonatal lung injury and alveolar simplification in mice[J]. Pediatr Res, 2022, 91(6):1405-1415.
|
[8] |
ATREYA M R, CVIJANOVICH N Z, FITZGERALD J C, et al. Detrimental effects of PCSK9 loss-of-function in the pediatric host response to sepsis are mediated through independent influence on Angiopoietin-1[J]. Crit Care, 2023, 27(1):250.
|
[9] |
YUAN H T, KHANKIN E V, KARUMANCHI S A, et al. Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium[J]. Mol Cell Biol, 2009, 29(8):2011-2022.
doi: 10.1128/MCB.01472-08
pmid: 19223473
|
[10] |
ZIEGLER T, HORSTKOTTE J, SCHWAB C, et al. Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis. J Clin Invest, 2013, 123(8):3436-3445.
|
[11] |
RICHTER R P, ASHTEKAR A R, ZHENG L, et al. Glycocalyx heparan sulfate cleavage promotes endothelial cell angiopoietin-2 expression by impairing shear stress-related AMPK/FoxO1 signaling[J]. JCI Insight, 2022, 7(15):e155010.
|
[12] |
LUKASZ A, HILLGRUBER C, OBERLEITHNER H, et al. Endothelial glycocalyx breakdown is mediated by angiopoietin-2[J]. Cardiovasc Res, 2017, 113(6):671-680.
doi: 10.1093/cvr/cvx023
pmid: 28453727
|
[13] |
DROST C C, ROVAS A, KUSCHE-VIHROG K, et al. Tie2 activation promotes protection and reconstitution of the endothelial glycocalyx in human sepsis[J]. Thromb Haemost, 2019, 119(11):1827-1838.
|
[14] |
付绪哲, 柳英杰, 牛明明, 等. 脓毒症免疫抑制机制的研究进展[J]. 中国临床研究, 2023, 36(5):741-745.
|
|
FU X Z, LIU Y J, NIU M M, et al. Research progress in immunosuppressive mechanism of sepsis[J]. Chin J Clin Res, 2023, 36(5):741-745.
|
[15] |
SMADJA D M, GUERIN C L, CHOCRON R, et al. Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients[J]. Angiogenesis, 2020, 23(4):611-620.
doi: 10.1007/s10456-020-09730-0
pmid: 32458111
|
[16] |
FIEDLER U, REISS Y, SCHARPFENECKER M, et al. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation[J]. Nat Med, 2006, 12(2):235-239.
doi: 10.1038/nm1351
pmid: 16462802
|
[17] |
LASK A, GUTBIER B, KERSHAW O, et al. Adjunctive therapy with the Tie2 agonist Vasculotide reduces pulmonary permeability in Streptococcus pneumoniae infected and mechanically ventilated mice[J]. Sci Rep, 2022, 12(1):15531.
doi: 10.1038/s41598-022-19560-3
pmid: 36109537
|
[18] |
IDOWU T O, ETZRODT V, SEELIGER B, et al. Identification of specific Tie2 cleavage sites and therapeutic modulation in experimental sepsis[J]. Elife, 2020, 9:e59520.
|
[19] |
闫威威, 董思琴, 汪华学. 红细胞分布宽度与血小板计数比值对脓毒症患者预后的预测价值[J]. 安徽医学, 2022, 43(8):887-891.
|
|
YAN W W, DONG S Q, WANG H X. The predictive value of the ratio of red blood cell distribution width to platelet count for the prognosis of sepsis patients[J]. Anhui Med J, 2022, 43(8):887-891.
|
[20] |
HIGGINS S J, DE CEUNYNCK K, KELLUM J A, et al. Tie2 protects the vasculature against thrombus formation in systemic inflammation[J]. J Clin Invest, 2018, 128(4):1471-1484.
doi: 10.1172/JCI97488
pmid: 29360642
|
[21] |
SCHMAIER A A, PAJARES HURTADO G M, MANICKAS-HILL Z J, et al. Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19[J]. JCI Insight, 2021, 6(20):e151527.
|
[22] |
SZEDERJESI J, ALMASY E, LAZAR A, et al. The Role of Angiopoietine-2 in the Diagnosis and Prognosis of Sepsis[J]. J Crit Care Med (Targu Mures), 2015, 1(1):18-23.
|
[23] |
CALFEE C S, JANZ D R, BERNARD G R, et al. Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies[J]. Chest, 2015, 147(6):1539-1548.
doi: S0012-3692(15)37209-3
pmid: 26033126
|
[24] |
RICHTER R P, ZHENG L, ASHTEKAR A R, et al. Associations of Plasma Angiopoietins-1 and -2 and Angiopoie-tin-2/-1 Ratios With Measures of Organ Injury and Clinical Outcomes in Children With Sepsis: A Preliminary Report[J]. Pediatr Crit Care Med, 2020, 21(9):e874-e878.
|
[25] |
PRICE D R, BENEDETTI E, HOFFMAN K L, et al. Angiopoietin 2 is associated with vascular necroptosis induction in coronavirus disease 2019 acute respiratory distress syndrome[J]. Am J Pathol, 2022, 192(7):1001-1015.
|
[26] |
REILLY J P, WANG F, JONES T K, et al. Plasma angiopoietin-2 as a potential causal marker in sepsis-asso-ciated ARDS development: evidence from Mendelian randomization and mediation analysis[J]. Intensive Care Med, 2018, 44(11):1849-1858.
|
[27] |
ROSENBERGER C M, WICK K D, ZHUO H, et al. Early plasma angiopoietin-2 is prognostic for ARDS and morta-lity among critically ill patients with sepsis[J]. Crit Care, 2023, 27(1):234.
|
[28] |
YU W K, MCNEIL J B, WICKERSHAM N E, et al. Angiopoietin-2 outperforms other endothelial biomarkers associated with severe acute kidney injury in patients with severe sepsis and respiratory failure[J]. Crit Care, 2021, 25(1):48.
|
[29] |
ATREYA M R, CVIJANOVICH N Z, FITZGERALD J C, et al. Prognostic and predictive value of endothelial dysfunction biomarkers in sepsis-associated acute kidney injury: risk-stratified analysis from a prospective observational cohort of pediatric septic shock[J]. Crit Care, 2023, 27(1):260.
|
[30] |
FANG Y, LI C, SHAO R, et al. The role of biomarkers of endothelial activation in predicting morbidity and morta-lity in patients with severe sepsis and septic shock in intensive care: A prospective observational study[J]. Thromb Res, 2018, 171:149-154.
|
[31] |
KIM W Y, KWEON O J, CHA M J, et al. Dexamethasone may improve severe COVID-19 via ameliorating endothelial injury and inflammation: A preliminary pilot study[J]. PLoS One, 2021, 16(7):e0254167.
|
[32] |
KNAUP H, STAHL K, SCHMIDT B M W, et al. Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers[J]. Crit Care, 2018, 22(1):285.
|
[33] |
HOFMAENNER D A, DAVID S. From Angiopoietin-2 to basic chemistry: differential effects of statins on endothelial homeostasis in ARDS[J]. Crit Care, 2023, 27(1):183.
|
[34] |
JIANG S, LI S, HU J, et al. Combined delivery of angiopoietin-1 gene and simvastatin mediated by anti-intercellular adhesion molecule-1 antibody-conjugated ternary nanoparticles for acute lung injury therapy[J]. Nanomedicine, 2019, 15(1):25-36.
doi: S1549-9634(18)30513-6
pmid: 30193816
|
[35] |
JONES R S, SMITH P S, BERG P H, et al. Efficacy and safety of LY3127804, an anti-angiopoietin-2 antibody, in a randomized, double-blind, placebo-controlled clinical trial in patients hospitalized with pneumonia and presumed or confirmed COVID-19[J]. Clin Med Insights Circ Respir Pulm Med, 2022, 16:11795484221119316.
|